VieCell Institute of Regenerative Medicine

What VieCell Institute of Regenerative Medicine does

VieCell Institute of Regenerative Medicine is a private, single-site stem cell therapy hospital headquartered in Surat, Gujarat, India. The company provides regenerative medicine treatments utilizing stem cell therapy for various medical conditions, delivering these procedures directly to individual patients at its clinical facility. Its product portfolio is narrow, consisting of a single core service line — stem cell-based medical treatments — with no additional product lines, ancillary services, or productized technology offerings disclosed in the source material.

The business is small-scale, with 8 reported employees and no disclosed management team, investors, or board. No funding rounds, partnerships, certifications, or regulatory approvals are recorded. The company has an active website (viecells.com) suggesting continued operations, but there are no disclosed pricing models, customer segments, or revenue figures. Operating geographies are limited to South Asia (India), with no global footprint claim and no evidence of cross-border patient services or telemedicine.

The business model appears to be fee-for-service clinical care delivered in person, typical of small specialty medical practices in India. There are no enterprise clients, B2B contracts, distribution channels, or marketing channels documented. Overall, the available evidence describes a micro-scale specialty clinical practice with no disclosed growth, expansion, or strategic activity beyond its existing Surat operation.

Name

VieCell Institute of Regenerative Medicine

Legal name

VieCell Institute of Regenerative Medicine

Website

https://viecells.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

VieCell Institute of Regenerative Medicine is an 8-employee, single-site stem cell therapy hospital in Surat, Gujarat, India, providing regenerative medicine treatments to individual patients on a fee-for-service basis.

Ownership category

akta.pro rank

Product category

Regenerative Medicine

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYHLAAAGAA

Stem Cell–Based Regenerative Therapies

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

SECONDARYHLAAABAE

Stem Cell Therapies (MSC/iPSC/HSC-derived)

Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)

SECONDARYHLAAABAJ

Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring)

Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)

Keywords

• Stem cell therapy
• Regenerative medicine
• Cell-based treatments
• Biological therapeutics
• Clinical stem cell services

Headquarters

HQ city

Surat

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure

Core offering

VieCell Institute of Regenerative Medicine operates as a stem cell therapy hospital based in Surat, Gujarat, India. It delivers regenerative medicine treatments utilizing stem cell therapy for various medical conditions, providing patient-facing clinical care at its physical hospital facility. The portfolio consists of a single primary service line focused on stem cell-based medical treatments.

Product overview

VieCell Institute of Regenerative Medicine is a stem cell therapy hospital providing regenerative medicine services. The company offers stem cell therapy treatments as its core service offering at its facility in Surat, Gujarat, India. The portfolio consists of a single primary service line focused on stem cell-based medical treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Stem Cell Therapy Services Regenerative medicine treatments utilizing stem cell therapy for various medical conditions, delivered to individual patients at the hospital facility in Surat, Gujarat, India.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Advancells: India-based stem cell therapy provider offering regenerative treatments for multiple indications. Directly comparable to VieCell as both operate stem cell therapy clinics in India targeting similar domestic and medical tourism patient segments.
• CellGenix (India stem cell therapy providers): Indian stem cell treatment provider offering regenerative therapies across multiple specialties. Comparable to VieCell as a regional stem cell clinical services provider competing for similar patient demographics.
• Regrow Biosciences: Mumbai-based regenerative medicine company developing and providing cell-based therapies including chondrocyte and stem cell treatments. Comparable as an India-focused stem cell/cell therapy clinical services provider with hospital and clinical partnerships.
• StemGenn Therapeutics: India-based stem cell therapy and regenerative medicine provider offering treatments for orthopedic, neurological, and cosmetic indications. Directly comparable in service portfolio and Indian operating context.
• StemRx Bioscience Solutions: India-based regenerative medicine and stem cell therapy company providing autologous and allogeneic cell therapies. Directly competes with VieCell in the Indian stem cell therapy services market with similar offerings and patient profiles.

Broad incumbents

• Celltex Therapeutics: Houston-based adult stem cell therapy provider offering autologous MSC treatments. Comparable as an established clinical services stem cell therapy player, though operating in a different geographic market.
• Stem Cell Institute (Panama): Long-standing stem cell treatment clinic in Panama City specializing in regenerative therapies with strong medical-tourism positioning. Comparable as a specialty clinical stem cell services provider leveraging international patient demand.
• Stemcyte: US/global cord blood banking and stem cell therapeutics company with established clinical operations. Broader incumbent in the stem cell therapy and regenerative medicine space; provides scale and credentialing reference for the category.

Emerging players

• TotipotentRX (CX Vascular / TotiPotent): India-headquartered regenerative medicine company with cell therapy development capabilities. Comparable in India-centric stem cell/cell therapy focus but with broader R&D and clinical pipeline positioning than a pure services play like VieCell.
• Stempeutics Research: Bengaluru-based stem cell company developing MSC-based therapies for commercial use. Comparable in India stem cell therapy context but operates more on the biopharma product-development side, providing a reference point for clinical-grade competition.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/viecells

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VieCell Institute of Regenerative Medicine